Cholecystectomy in cirrhotic patients: a formidable operation

Area of Science:

• Hepatology
• Gastroenterology
• Surgical Oncology

Background:

• Cirrhotic patients undergoing cholecystectomy face significant risks.
• Prolonged prothrombin time indicates severe liver dysfunction and predicts poor surgical outcomes.

Purpose of the Study:

• To evaluate the mortality associated with cholecystectomy and common bile duct exploration in cirrhotic patients.
• To identify risk factors and guide surgical decision-making in this high-risk population.

Main Methods:

• Retrospective analysis of cirrhotic patients undergoing biliary tract surgery.
• Correlation of preoperative prothrombin time with intraoperative complications and mortality.

Main Results:

• An 83% mortality rate was observed in cirrhotic patients with prothrombin time prolonged by 2.5 seconds over control.
• Prolonged prothrombin time predicted massive blood loss and transfusion needs.
• Jaundice in cirrhosis is typically hepatocellular, not obstructive, complicating preoperative assessment.

Conclusions:

• Cholecystectomy and common bile duct exploration in cirrhotic patients are associated with high mortality, especially with coagulopathy.
• Indications for surgery must be limited to life-threatening biliary conditions such as empyema, perforation, and ascending cholangitis.
• Careful preoperative evaluation is crucial, considering the high risk of complications related to liver disease.